Search Results - "Dignass, A. U."

Refine Results
  1. 1

    Escherichia coli Strain Nissle 1917 Ameliorates Experimental Colitis via Toll-Like Receptor 2- and Toll-Like Receptor 4-Dependent Pathways by Grabig, A, Paclik, D, Guzy, C, Dankof, A, Baumgart, D.C, Erckenbrecht, J, Raupach, B, Sonnenborn, U, Eckert, J, Schumann, R.R, Wiedenmann, B, Dignass, A.U, Sturm, A

    Published in Infection and Immunity (01-07-2006)
    “…Toll-like receptors (TLRs) are key components of the innate immune system that trigger antimicrobial host defense responses. The aim of the present study was…”
    Get full text
    Journal Article
  2. 2

    Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease by Baumgart, D. C., Wiedenmann, B., Dignass, A. U.

    Published in Alimentary pharmacology & therapeutics (15-05-2003)
    “…Summary Background : Oral tacrolimus, approved for the prophylaxis of organ rejection in liver or kidney transplants, has been reported to be effective in…”
    Get full text
    Journal Article
  3. 3

    Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells by Baumgart, D C, Metzke, D, Schmitz, J, Scheffold, A, Sturm, A, Wiedenmann, B, Dignass, A U

    Published in Gut (01-02-2005)
    “…Background: Breakdown of tolerance against the commensal microflora is believed to be a major factor in the pathogenesis of inflammatory bowel disease (IBD)…”
    Get full text
    Journal Article
  4. 4

    Clinical trial: five or ten cycles of granulocyte–monocyte apheresis show equivalent efficacy and safety in ulcerative colitis by DIGNASS, A. U., ERIKSSON, A., KILANDER, A., PUKITIS, A., RHODES, J. M., VAVRICKA, S.

    Published in Alimentary pharmacology & therapeutics (01-06-2010)
    “…Aliment Pharmacol Ther 31, 1286–1295 Summary Background  Ulcerative colitis is characterized by leucocyte infiltration into the colonic mucosa…”
    Get full text
    Journal Article
  5. 5

    Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel by Pascu, M., Roznowski, A. B., Müller, H‐P., Adler, A., Wiedenmann, B., Dignass, A. U.

    Published in Inflammatory bowel diseases (01-07-2004)
    “…Background: Ileocolonoscopy represents the diagnostic standard in the work‐up of patients with inflammatory bowel diseases (IBD). Patients are often reluctant…”
    Get full text
    Journal Article
  6. 6

    Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta by Dignass, A U, Podolsky, D K

    Published in Gastroenterology (New York, N.Y. 1943) (01-11-1993)
    “…After various forms of superficial injury, mucosal integrity is re-established by rapid migration of epithelial cells across the wound margins in a process…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid by Sturm, Andreas, Sudermann, Thomas, Schulte, Klaus–Martin, Goebell, Harald, Dignass, Axel U.

    Published in Gastroenterology (New York, N.Y. 1943) (01-08-1999)
    “…Background & Aims: Lysophosphatidic acid (LPA) is assumed to play an important role in the modulation of injury and tissue repair in nonepithelial tissues. The…”
    Get full text
    Journal Article
  9. 9

    Bone Loss in Patients with Inflammatory Bowel Disease Is Less Than Expected: A Follow-up Study by SCHULTE, C, DIGNASS, A. U, MANN, K, GOEBELL, H

    “…In spite of the accumulating evidence of an increased prevalence of osteopenia and osteoporosis in patients with inflammatory bowel diseases (IBD), the time…”
    Get full text
    Journal Article
  10. 10

    Effects of exogenous zinc supplementation on intestinal epithelial repair in vitro by CARIO, E, JUNG, S, HARDER D'HEUREUSE, J, SCHULTE, C, STURM, A, WIEDENMANN, B, GOEBELL, H, DIGNASS, A. U

    Published in European journal of clinical investigation (01-05-2000)
    “…Background Substitution of zinc modulates antioxidant capabilities within the intestinal mucosa and improves intestinal wound healing in zinc‐deficient…”
    Get full text
    Journal Article
  11. 11

    Fibroblast growth factors modulate intestinal epithelial cell growth and migration by Dignass, A U, Tsunekawa, S, Podolsky, D K

    Published in Gastroenterology (New York, N.Y. 1943) (01-05-1994)
    “…Various peptide growth factors have been found to exert functional effects among epithelial cell populations. This study assessed the role of certain…”
    Get more information
    Journal Article
  12. 12

    Functional Relevance of Activin A in the Intestinal Epithelium by Dignass, A. U., Jung, S., Harder-d'Heureuse, J., Wiedenmann, B.

    Published in Scandinavian journal of gastroenterology (01-08-2002)
    “…Background: Activin A modulates inflammation and repair in various tissues. The aim of this study was to characterize the effects of activin A on intestinal…”
    Get full text
    Journal Article
  13. 13

    Acute epithelial injury in the rat small intestine in vivo is associated with expanded expression of transforming growth factor alpha and beta by Dignass, A U, Stow, J L, Babyatsky, M W

    Published in Gut (01-05-1996)
    “…BACKGROUND--Previous studies have shown the importance of transforming growth factors alpha and beta (TGF alpha and TGF beta) in modulating epithelial cell…”
    Get full text
    Journal Article Conference Proceeding
  14. 14
  15. 15

    Shingles following infliximab infusion by Baumgart, D C, Dignass, A U

    Published in Annals of the rheumatic diseases (01-07-2002)
    “…DISCUSSION Adult varicella can be a severe illness complicated by pneumonia, encephalitis, hepatitis, thrombocytopenia, and prolonged fever. 3 Blood levels of…”
    Get full text
    Journal Article
  16. 16

    A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding by Schröder, O, Schrott, M, Blumenstein, I, Jahnel, J, Dignass, A U, Stein, J

    Published in Zeitschrift für Gastroenterologie (01-08-2004)
    “…The provision of adequate iron to support erythropoiesis in iron deficient patients is a time-consuming process which may present compliance problems for…”
    Get more information
    Journal Article
  17. 17

    Adenine nucleotides modulate epithelial wound healing in vitro by DIGNASS, A. U, BECKER, A, SPIEGLER, S, GOEBELL, H

    Published in European journal of clinical investigation (01-07-1998)
    “…Background Adenine nucleotides have been demonstrated to enhance structural and functional regeneration in experimental renal injury in rats. The mechanisms of…”
    Get full text
    Journal Article
  18. 18

    Current position on Vedolizumab for ulcerative colitis and Crohn's disease by Schreiber, S, Dignass, A U, Hartmann, H, Kruis, W, Rogler, G, Siegmund, B, Stallmach, A, Witte, C, Bokemeyer, B

    Published in Zeitschrift fur Gastroenterologie (01-06-2015)
    “…Vedolizumab, the first drug in the class of anti-integrin molecules, is newly approved for ulcerative colitis and Crohn's disease and can be prescribed in…”
    Get more information
    Journal Article
  19. 19

    Mechanisms and modulation of intestinal epithelial repair by Dignass, Axel U.

    Published in Inflammatory bowel diseases (01-02-2001)
    “…The mucosal epithelium of the alimentary tract represents a crucial barrier to a broad spectrum of noxious and immunogenic substances within the intestinal…”
    Get full text
    Journal Article
  20. 20

    Mycophenolate mofetil reduces tissue damage and inflammation in an experimental model of colitis in rats by ZEEH, J. M, ZORLU, I, RILEY, N. E, HOFFMANN, P, RUWE, M, GOEBELL, H, GERKEN, G, DIGNASS, A. U

    “…Lymphocytes are widely believed to be responsible for persistent intestinal inflammation in inflammatory bowel diseases. Mycophenolate mofetil (MMF) is a…”
    Get full text
    Journal Article